Op-Ed
Perspectives and candid discussion on cancer care, treatment decisions, and the healthcare system.
The Promise and Peril of Multi-Cancer Early Detection Tests
GRAIL's Galleri test and similar MCED blood tests are now commercially available and genuinely exciting — but the data on false positives and cascade harm deserves an honest conversation before you order one.
Read more →Why Every Cancer Patient Should Demand a Second Opinion — and How to Do It Without Awkwardness
Getting a second opinion isn't disloyalty — it's medicine. Here's the data behind why treatment plans vary so dramatically between institutions, and exactly how to ask.
Read more →The Promise and Peril of Multi-Cancer Early Detection Tests
GRAIL's Galleri test and similar MCED blood tests are now commercially available and genuinely exciting — but the data on false positives and cascade harm deserves an honest conversation before you order one.
Read more →Why Every Cancer Patient Should Demand a Second Opinion — and How to Do It Without Awkwardness
Getting a second opinion isn't disloyalty — it's medicine. Here's the data behind why treatment plans vary so dramatically between institutions, and exactly how to ask.
Read more →Insurance Barriers in Cancer Care Are Costing Lives u2014 And What We Can Do About It
When prior authorization delays prevent patients from starting curative treatment on time, the consequences are not administrative u2014 they are clinical. It is time to change this.
Read more →